# AbOliGo jobs and careers

> 0 open roles at AbOliGo as of October 23, 2026. Source: https://www.thejobsmap.com/company/aboligo

AbOliGo (Cambridge UK, founded 2024) is developing a revolutionary platform for rapid, small-scale production of antibody-oligonucleotide conjugates (AOCs), addressing a critical bottleneck in multiplexing. AOCs are transformative tools that combine antibodies' exquisite targeting specificity with oligonucleotides' properties - DNA amplification and molecular barcoding, enabling unlimited multiplexing. However, while there are approximately 7 million commercially available antibodies, only ~0.03% are offered as AOCs. Recognizing the growing demand for AOCs, we aim to innovate and re-imagine the manufacturing process through three key technological advancements: Scale - A novel conjugation methodology that enables production at µg scale. Quality – Develop a QC quantitative release criteria, guaranteeing batch consistency. Fast – Manufacture and deliver AOCs from a large portfolio within days.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | United Kingdom |
| Employees | 1 to 10 |
| Website | https://aboligo.com |

## Leadership

- Brian Carpenter, CEO and Co-Founder

## Common questions

### Is AbOliGo hiring right now?

AbOliGo has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on AbOliGo's careers site.

### Where is AbOliGo headquartered?

AbOliGo is headquartered in United Kingdom.

### Who leads AbOliGo?

Brian Carpenter, CEO and Co-Founder, is at the top of AbOliGo's org chart.

### How do I apply for a job at AbOliGo?

Pick a role on AbOliGo's TheJobsMap page and select Apply. Every listing links to the original posting on AbOliGo's own careers site, so you apply directly with the employer.